Auto Injectors Market Size, Share, Trends, Analysis and Forecasts To 2022
Global Auto Injectors Market is accounted for $ 1.10 billion in 2015 and is expected to reach $ 3.78 billion by 2022 growing at a CAGR of 19.42 %. As large number of patients are opting for self administered treatment and care there is a flawless increase in use of Auto Injectors. Moreover, the high prevailing patients of anaphylaxis had presented a huge demand for the market which seems as pertaining factor behind the market growth. At the same time high cost and need for utmost care are some of the factors hampering the market.
Download Sample Report @ https:// marketreportscenter. com / request-sample / 328749
Prefilled Syringes in primary drug container segment seems to be predominant in market segment because of the dramatic effect on the way injectable drugs are developed, prescribed and administered. Anaphylaxis in the therapeutic application segment will be dominant throughout the forecast period, as more people are allergic and nauseous. While North America being the largest market, Asia pacific hails as fastest growing because of channeling investments into China and India and improving consumer awareness through marketing campaigns.
Some of the major key players of the market are Unilife Corporation, Novartis International AG, Becton, Dickinson and Company, Antares Pharma, Inc., Mylan, Inc., Adamis Pharmaceuticals Corp, Hospira Inc, Scandinavian Health Limited( SHL) Group, Sanofi SA, Itelliject Inc, Pfizer, Inc., Lincoln Medical Ltd, Ypsomed Holdings AG, ALK Abello, Teva Pharmaceuticals Ltd and Biogen Idec, Inc.
Devices Covered: Smart Autoinjectors Product Specific Autoinjectors Manual Injection Autoinjectors Disposable Autoinjectors Reusable Autoinjectors Variable Dose Autoinjectors Automated Injection Autoinjectors
Product Types Covered: Standardized Auto-injectors Customized Auto-injectors
Therapeutic Applications covered: Autoimmune Diseases Anaphylaxis Anticoagulants Neurology